C. Sp, Elle a montré une efficacité similaire mais une moindre toxicité de la caspofungine

A. Defranco, M. Robertson, and R. Locksley, La réponse immunitaire des les maladies infectieuses et inflammatoires, pp.118-166, 2007.

L. P. Samaranayake and T. W. Mac-farlane, Factors affecting the in-vitro adherence of the fungal oral pathogen Candida albicans to epithelial cells of human origin, Archives of Oral Biology, vol.27, issue.10, pp.869-873, 1982.
DOI : 10.1016/0003-9969(82)90043-7

A. Darwazeh, P. Lamey, . Samaranayake, and T. W. Mac-farlane, The relationschip between oral yeast colonization and in vitro adhesion of candida to buccal cell of diabetics

R. M. Wilson and W. G. Reeves, Neutrophil phagocytosis and killing in insulin-dependent diabetes, J Med Microbiol, vol.33, pp.43-49, 1990.

D. Trofa, . Gascer, and J. Nosanchuk, Candida parapsilosis, an Emerging Fungal Pathogen, Clinical Microbiology Reviews, vol.21, issue.4, pp.606-620, 2008.
DOI : 10.1128/CMR.00013-08

URL : http://cmr.asm.org/content/21/4/606.full.pdf

. Pauw, P. De, and . Rex, Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group, Clinical Infectious Diseases, vol.285, issue.12, pp.1813-1821, 2003.
DOI : 10.1086/518852

H. Richet and P. Et-roux, Clin Microbial Infect, pp.405-412, 2002.

C. Leon, A bedside scoring system ("Candida score") for early antifungical treatment

A. Khlif, H. Sellami, . Sellami, A. L. Makni, . Piarroux et al., Candida dubliniensis: Identification methods and epidemiologic implication Physiopathology of oropharyngeal candidosis in HIV-infected patients Medecine et Maladies infectieuses Candidose oropharyngée récidivante à Candida albicans chez un patient infecté par le VIH. Aspect mycologique génotypique et immunologique, Pathol Biol. 14. Million, 15. Million, J Mycol Med Oral Microbiol Immunol, vol.59, issue.17, pp.166-172, 2001.

. Les, H and vénérologie, service de dermatologie. (photo) 20. www.chir-dent.org/t3292-la-perleche. (photo) 21. www.therapeutique-dermatologique.org. (photo) 22. http://umvf.univ-nantes.fr/chirurgie-maxillo-faciale-et-stomatologie/enseignement. (photo) 23

E. Leon, . Jacober, J. Sobel, and B. Foxman, Prevalence and risk factors for vaginal

W. Damaceno, F. Vidal, and F. Ferreira, Candida colonization in women with type 1 and type 2 diabetes Evolution of IgA deficiency to, BMC Infect Dis, vol.2, 2002.

A. Casadevall, Antibody-mediated regulation of cellular immunity and the inflammatory response, Trends in Immunology, vol.24, issue.9, pp.474-478, 2003.
DOI : 10.1016/S1471-4906(03)00228-X

P. Fidel and J. Et-cutler, Prospects for Development of a Vaccine to Prevent and Control Vaginal Candidiasis, Current Infectious Disease Reports, vol.197, issue.1, pp.102-107, 2011.
DOI : 10.1086/529204

P. Eggiman and D. Pittet, Candidoses invasives en réanimation, pp.1525-1537, 2000.

S. Abdennader, . Casin, . Janier, . Zavaro, and F. Traore, Balanites et agents infectieux Etude prospective de 100 cas, Ann Dermatol Venereol, vol.122, pp.580-584, 1995.

A. Abdullah, . Drake, . Wade, and M. Walzman, Balanitis (Balanoposthitis) in Patients Attending a Department of Genitourinary Medicine, International Journal of STD & AIDS, vol.82, issue.2, pp.128-129, 1992.
DOI : 10.1097/00007435-198010000-00012

D. Pittet, . Monod, and E. Frenk, Candida colonization and subsequent infections in critically surgical patients. Ann surg, pp.751-758, 2006.

J. Waller, H. Koenig, . Chambet, and M. Kremer, Limites du test de filamentation en sérum pour l'identification de Candida albicans, J Mycol Med, vol.12, pp.144-145, 1995.

G. Quindos, Utility of fluoroplate Candida for rapid identification of Candida albicans, Infect Microbio et Clin, vol.14, pp.586-589, 2000.

C. Campbelle, . Davey, . Holmes, and A. Szekely, Comparaison of the API Candida system with the auxacolor system for identification of common yeast pathogens, J Clin Microbiol, vol.37, pp.821-823, 1999.

J. Waller, Evaluation d'un nouveau système d'identification des levures fungichrom basé sur l'hydrolyse des substrats et l'assimilation colorimétrique des sucres, J

A. Elllepola, S. Hurst, C. Elie, and C. Morrison, Rapid and unequivocal differenciation of Candida dubliniensis from other Candida species using species specidfis DNA probes: comparaison with phenotypic identification method. Laboratory diagnosis of invasive candidiasis, J Microbiol, vol.43, pp.65-84, 2003.

E. Eraso and M. Moragues, Evaluation of the New Chromogenic Medium Candida ID 2 for Isolation and Identification of Candida albicans and Other Medically Important Candida Species, Journal of Clinical Microbiology, vol.44, issue.9, pp.3340-3345, 2006.
DOI : 10.1128/JCM.00213-06

Z. Khan, . Ahmad, and E. Mokaddas, Sunflower seed husk agar: A new medium for the differentiation of Candida dubliniensis from Candida albicans, Indian Journal of Medical Microbiology, vol.23, issue.3, pp.182-185, 2005.
DOI : 10.4103/0255-0857.16605

O. Momami and A. Qaddoomi, Identification of Candida dubliniensis in a diagnostic microbiology laboratory, East Mediterr Health J, vol.11, pp.366-371, 2005.

D. Ellis, Amphotericin B: spectrum and resistance, Journal of Antimicrobial Chemotherapy, vol.49, issue.suppl 1, pp.7-10, 2002.
DOI : 10.1093/jac/49.suppl_1.7

S. Kelly and D. Lamb, Resistance to fluconazole and amphotericin in Candida albicans from AIDS patients, The Lancet, vol.348, issue.9040, pp.1523-1524, 1996.
DOI : 10.1016/S0140-6736(05)65949-1

K. Marr, K. Seidel, and T. White, Candidemia in Allogeneic Blood and Marrow Transplant Recipients: Evolution of Risk Factors after the Adoption of Prophylactic Fluconazole, The Journal of Infectious Diseases, vol.181, issue.1, pp.309-316, 2006.
DOI : 10.1086/315193

J. Maenza, . Keruly, and R. Et-moore, Risk Factors for Fluconazole-Resistant Candidiasis in Human Immunodeficiency Virus-Infected Patients, Liposomal amphotericin B: what is the role, pp.219-225, 1996.
DOI : 10.1093/infdis/173.1.219

L. Johnson and C. Kauffman, Voriconazole: A New Triazole Antifungal Agent, Clinical Infectious Diseases, vol.12, issue.5, pp.630-637, 2003.
DOI : 10.1128/AAC.45.2.601-604.2001

M. Pappas and J. Runhke, Voriconazole versus a regimen of amphotericin B followed by fluconazole, Lancet, vol.366, pp.1435-1442, 2005.

J. Mora-duarte, R. Betts, and A. Colombo, Comparaison of caspofungin and amphotericin B for invasive candidasis, N Engl J Med, vol.19, pp.2020-2029, 2002.

P. Pappas, C. L. Et-kauffmann, and C. Kibbler, Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America, Clinical Infectious Diseases, vol.48, issue.5, pp.503-535, 2004.
DOI : 10.1086/596757

E. Velasco, R. Bigni, . Sofair, . Harrison, G. Lyon et al., A prospective cohort study evaluating the prognostic impact of clinical characteristics and comorbid conditions of hospitalized adult and pediatric cancer patients with candidemia, European Journal of Clinical Microbiology & Infectious Diseases, vol.22, issue.11, pp.1071-1078, 2004.
DOI : 10.1093/clinids/23.3.506

B. Almirante, D. Rodriguez, . Park, . Planes, and M. Almela, Epidemiology and Predictors of Mortality in Cases of Candida Bloodstream Infection: Results from Population-Based Surveillance, Barcelona, Spain, from 2002 to 2003, Journal of Clinical Microbiology, vol.43, issue.4, pp.1829-1835, 2005.
DOI : 10.1128/JCM.43.4.1829-1835.2005

P. Pappas, J. Rex, . Lee, . Hamill, R. Larsen et al., A Prospective Observational Study of Candidemia: Epidemiology, Therapy, and Influences on Mortality in Hospitalized Adult and Pediatric Patients, Clinical Infectious Diseases, vol.32, issue.8, pp.634-677, 2003.
DOI : 10.1086/319763

M. Morrell, . Fraser, and M. Et-kollef, Delaying the Empiric Treatment of Candida Bloodstream Infection until Positive Blood Culture Results Are Obtained: a Potential Risk Factor for Hospital Mortality, Antimicrobial Agents and Chemotherapy, vol.49, issue.9, pp.3640-3645, 2005.
DOI : 10.1128/AAC.49.9.3640-3645.2005